BRISBANE, Calif., Dec. 19, 2013 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced further enhancements to its sales and marketing organization.
Scott Ashworth recently joined Cutera as Executive Vice President of Global Sales. He brings twenty-five years of experience in building and leading global sales and marketing teams focused on commercialization of products, establishing distribution partnerships, and other leadership roles in medical technology companies. Scott started his career as a sales representative at Hewlett Packard Medical Products Group and then progressed to positions of increasing responsibility at Acuson/Siemens, and Heartflow. Prior to joining Cutera, Scott was Senior Vice President of Global Sales at Avinger.
Kevin Connors, President and CEO of Cutera, stated, "Scott's extensive multi-national, medical device management experience further strengthens our commercial leadership team as we continue to augment the strength of this part of our organization. Ollie Reese, Director of North American Sales, will continue to play a pivotal leadership role on Scott's team. Scott will initially be focused on the North American sales organization and will transition over time to assume international sales responsibilities. With our strengthened commercial leadership team, we are well positioned to capture an appropriate improved performance, given our existing broad product portfolio and planned new launches."
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's ability to increase revenue, develop and commercialize existing and new products and applications, meet expectation for new product launch dates, achieve profitability, and statements regarding long-term prospects and opportunities in the laser and other energy-based equipment aesthetic market are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include those related to the Company's efforts to improve sales productivity, revenue growth and profitability improvement through the expansion of its executive management team, successfully develop and launch new products and applications and market them to both its installed base and new customers, unforeseen events and circumstances relating to the Company's operations, government regulatory actions, and those other factors described in the section entitled, "Risk Factors" in its most recent Form 10-Q as filed with the Securities and Exchange Commission on November 4, 2013. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.